| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.004 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.47 | 0.006 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.46 | 0.006 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.007 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.007 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |